Knight Therapeutics (TSE:GUD) Trading 0.2% Higher – Still a Buy?

by · The Cerbat Gem

Shares of Knight Therapeutics Inc. (TSE:GUD – Get Free Report) rose 0.2% during mid-day trading on Thursday . The company traded as high as C$6.09 and last traded at C$6.05. Approximately 20,473 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 60,403 shares. The stock had previously closed at C$6.04.

Knight Therapeutics Stock Up 0.2%

The company has a current ratio of 3.36, a quick ratio of 1.79 and a debt-to-equity ratio of 7.52. The firm has a market capitalization of C$600.70 million, a P/E ratio of -151.25, a P/E/G ratio of -1,013.50 and a beta of 0.01. The stock’s 50-day simple moving average is C$5.94 and its 200-day simple moving average is C$6.06.

Knight Therapeutics (TSE:GUD – Get Free Report) last announced its earnings results on Thursday, November 6th. The company reported C($0.04) earnings per share for the quarter. The business had revenue of C$122.63 million during the quarter. Knight Therapeutics had a negative return on equity of 4.04% and a negative net margin of 8.81%. As a group, research analysts predict that Knight Therapeutics Inc. will post 0.1009486 earnings per share for the current fiscal year.

About Knight Therapeutics

(Get Free Report)

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company’s principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets.

See Also